Xeris Biopharma Holdings, Inc. Annual Interest Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Xeris Biopharma Holdings, Inc. quarterly/annual Interest Expense history and growth rate from 2020 to 2023.
  • Xeris Biopharma Holdings, Inc. Interest Expense for the quarter ending March 31, 2024 was $7.03M, a 13.1% increase year-over-year.
  • Xeris Biopharma Holdings, Inc. Interest Expense for the twelve months ending March 31, 2024 was $27.4M, a 63.3% increase year-over-year.
  • Xeris Biopharma Holdings, Inc. annual Interest Expense for 2023 was $26.6M, a 88.7% increase from 2022.
  • Xeris Biopharma Holdings, Inc. annual Interest Expense for 2022 was $14.1M, a 96.4% increase from 2021.
  • Xeris Biopharma Holdings, Inc. annual Interest Expense for 2021 was $7.18M, a 32.6% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $26.6M +$12.5M +88.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-06
2022 $14.1M +$6.92M +96.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $7.18M -$3.48M -32.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-06
2020 $10.7M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.